Evidence map›Paper›PMID 31701791›Full record

ArticleJournal of the American Heart Association2019

Predictors and Clinical Outcomes of Vasoplegia in Patients Bridged to Heart Transplantation With Continuous-Flow Left Ventricular Assist Devices.

Rabea Asleh, Hilmi Alnsasra, Richard C Daly, Sarah D Schettle, Alexandros Briasoulis, Riad Taher, Shannon M Dunlay, John M Stulak, Atta Behfar, Naveen L Pereira and 4 more

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Effects of Erythropoietin on Lung Injury Induced by Cardiopulmonary Bypass After Cardiac Surgery.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Rabea AslehDepartment of Cardiovascular Diseases Mayo Clinic Rochester MN.
Hilmi AlnsasraDepartment of Cardiovascular Diseases Mayo Clinic Rochester MN.
Richard C DalyDepartment of Cardiovascular Diseases Mayo Clinic Rochester MN.
Sarah D SchettleDepartment of Cardiovascular Diseases Mayo Clinic Rochester MN.
Alexandros BriasoulisDepartment of Cardiovascular Diseases Mayo Clinic Rochester MN.
Riad TaherDepartment of Cardiovascular Diseases Mayo Clinic Rochester MN.
Shannon M DunlayDepartment of Cardiovascular Diseases Mayo Clinic Rochester MN.
John M StulakDepartment of Cardiovascular Diseases Mayo Clinic Rochester MN.
Atta BehfarDepartment of Cardiovascular Diseases Mayo Clinic Rochester MN.
Naveen L PereiraDepartment of Cardiovascular Diseases Mayo Clinic Rochester MN.
Robert P FrantzDepartment of Cardiovascular Diseases Mayo Clinic Rochester MN.
Brooks S EdwardsDepartment of Cardiovascular Diseases Mayo Clinic Rochester MN.
Alfredo L ClavellDepartment of Cardiovascular Diseases Mayo Clinic Rochester MN.
Sudhir S KushwahaDepartment of Cardiovascular Diseases Mayo Clinic Rochester MN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background The presence of a durable left ventricular assist device (LVAD) is associated with increased risk of vasoplegia in the early postoperative period following heart transplantation (HT). However, preoperative predictors of vasoplegia and its impact on survival after HT are unknown. We sought to examine predictors and outcomes of patients who develop vasoplegia after HT following bridging therapy with an LVAD. Methods and Results We identified 94 patients who underwent HT after bridging with continuous-flow LVAD from 2008 to 2018 at a single institution. Vasoplegia was defined as persistent low vascular resistance requiring ≥2 intravenous vasopressors within 48 hours after HT for >24 hours to maintain mean arterial pressure >70 mm Hg. Overall, 44 patients (46.8%) developed vasoplegia after HT. Patients with and without vasoplegia had similar preoperative LVAD, echocardiographic, and hemodynamic parameters. Patients with vasoplegia were significantly older; had longer LVAD support, higher preoperative creatinine, longer cardiopulmonary bypass time, and higher Charlson comorbidity index; and more often underwent combined organ transplantation. In a multivariate logistic regression model, older age (odds ratio: 1.08 per year;

Indexed as

Heart-Assist DevicesHeart TransplantationAdultAgedAge FactorsCardiomyopathy, DilatedCardiopulmonary BypassCause of DeathComorbidityCreatinineFemaleHeart Defects, CongenitalHeart FailureHumansKidney TransplantationLiver TransplantationCreatinineheart transplantationleft ventricular assist deviceoutcomerisk factorsvasoplegia

Identifiers

PMID31701791
PMCPMC6915279

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.